223 related articles for article (PubMed ID: 16317269)
21. Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Liippo KK; Terho T
Acta Oncol; 1991; 30(3):321-4. PubMed ID: 1645171
[TBL] [Abstract][Full Text] [Related]
22. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
23. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
[TBL] [Abstract][Full Text] [Related]
24. Value of serum neuron-specific enolase in nonsmall cell lung cancer.
Diez M; Torres A; Ortega L; Maestro M; Hernando F; Gomez A; Picardo A; Granell J; Balibrea JL
Oncology; 1993; 50(2):127-31. PubMed ID: 8383830
[TBL] [Abstract][Full Text] [Related]
25. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
van Zandwijk N; Jassem E; Bonfrer JM; van Tinteren H
Eur J Cancer; 1990 Mar; 26(3):373-6. PubMed ID: 2162690
[TBL] [Abstract][Full Text] [Related]
26. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin.
Macchia V; Mariano A; Cavalcanti M; Coppa A; Cecere C; Fraioli G; Elia S; Ferrante G
Int J Biol Markers; 1987; 2(3):151-6. PubMed ID: 2836526
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
[TBL] [Abstract][Full Text] [Related]
29. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
30. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
31. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
32. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
Jin B; Zhao L; Zhou C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
[TBL] [Abstract][Full Text] [Related]
33. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
Mori Y; Hoshi H; Jinnouchi S; Harada K; Onoe K; Nagamachi S; Ozawa M; Watanabe K; Tawara Y
Radioisotopes; 1987 Feb; 36(2):78-80. PubMed ID: 3033753
[TBL] [Abstract][Full Text] [Related]
34. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
35. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
37. Reevaluaton of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase.
Gendreau V; Montravers F; Philippe C; Talbot JN
Int J Biol Markers; 1997; 12(4):148-53. PubMed ID: 9582603
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
[TBL] [Abstract][Full Text] [Related]
39. [Serum level of neuron-specific enolase: value as tumor marker of microcellular bronchial cancer].
Weynants P; Bauduin M; Majois F; Moens D; De Nayer P
Acta Clin Belg; 1989; 44(3):161-8. PubMed ID: 2554629
[TBL] [Abstract][Full Text] [Related]
40. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
